EMBLOK™ Embolic Protection System (EMBLOK EPS)
Sponsors
Emblok, Inc.
Conditions
AORTIC VALVE DISEASESAortic Valve DiseaseAortic Valve InsufficiencyAortic Valve RegurgitationAortic Valve ReplacementAortic Valve StenosisAortic Valve Stenosis and/or Insufficiency
Unknown Phase
Evaluation of Safety and Effectiveness of the EMBLOK EPS During TAVR
Active, not recruitingNCT05295628
Start: 2023-10-17End: 2025-10-01Target: 532Updated: 2025-08-06
Evaluation of Safety and Effectiveness of the EMBLOK EPS Compared With No Cerebral Embolic Protection During TAVR
Not yet recruitingNCT07129421
Start: 2025-10-21End: 2027-03-15Target: 560Updated: 2025-08-19